Antimicrobial Susceptibilities of Clinical Isolates of HACEK Organisms
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The “HACEK” organisms are a group of fastidious Gram-negative bacteria that cause a variety of infections, including infective endocarditis. Antimicrobial susceptibility testing is not universally available, and therapy for these infections is often empirical. We report the antimicrobial susceptibilities of 70 clinical HACEK isolates to 18 antimicrobials. All isolates were susceptible to ceftriaxone and levofloxacin, indicating that these agents remain appropriate empirical choices for the treatment of infections with this group of organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, β-lactamaseproducing strains of HACEK are appearing with increased frequency; rarely, resistance to ampicillin can occur in β-lactamase-negative strains.219”
From Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association (2015) · cites this paper as [219]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In 1 survey, 60% of isolates did not grow adequately in control wells, and no valid in vitro susceptibility results were available.219”
The cited source says what the claim attributes to it.
In the citing paper
“In addition, ampicillin-sulbactam may be considered a treatment option, although HACEK resistance to this agent in vitro has been described.219”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Jorgensen, J. H., & Clinical (2006) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,047
Gould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Gould, F. K. (2012) · Journal of Antimicrobial Chemotherapy · Cited by 193
Sheng, W.-S., Hsueh, P., Hung, C., Teng, L., Chen, Y., & Luh, K. T. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/pl00011259 · Cited by 84
Yagupsky, P., Katz, O., & Peled, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.2.191 · Cited by 80
Kugler, K. C., Biedenbach, D. J., & Jones, R. N. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00165-5 · Cited by 68 · cited 1×
“To our knowledge, only one study has described the antimicrobial susceptibilities of multiple genera of HACEK organisms, which included 42 clinical and American Type Culture Collection (ATCC) strains (4).”
Background16S Ribosomal DNA Typing for Identification of Pathogens in Patients with Bacterial Keratitis
Knox, C., Cevellos, V., & Dean, D. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.12.3492-3496.1998 · Cited by 56 · cited 1×
“Isolates were identified using either traditional biochemical tests or the 16S rRNA molecular assay (5).”
Method
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“In 1 survey, 60% of isolates did not grow adequately in control wells, and no valid in vitro susceptibility results were available.(219) Therefore, unless growth is adequate for in vitro screening, then HACEK microorganisms should be considered ampicillin resistant, and penicillin and ampicillin should not be used to…”
BackgroundInfluentialHolland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 179
HACEK endocarditis: state-of-the-art
Revest, M., Egmann, G., Cattoir, V., & Tattevin, P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1164032 · Cited by 139
“aphrophilus found susceptibility rates of 82% for penicillin, and 100% for ampicillin, amoxicillin-clavulanic acid, ceftriaxone, meropenem, and levofloxacin [19].”
BackgroundInfluentialInfective endocarditis by HACEK: a review
Khaledi, M., Sameni, F., Afkhami, H., Hemmati, J., Dezfuli, A. A. Z., Sanae, M.-J., & Validi, M. (2022) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-022-01932-5 · Cited by 134
“HACEK microorganisms cause disease such as periodontal infections, bacteremia, endocarditis, and polymicrobial wound infections [36] otitis media, and abscesses [36, 42, 43].”
Background
Metadata
- Authors
- Coburn, B., Toye, B., Rawte, P., Jamieson, F. B., Farrell, D. J., & Patel, S. N.
- Affiliations
- University of Toronto (CA)
- University of Ottawa (CA)
- Public Health Ontario (CA)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-04
- Volume
- 57
- Issue
- 4
- Pages
- 1989-1991
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC3623346
- OpenAlex
- W2102466313
- Semantic Scholar
- 3ae6fc88689befddd94564706405cc7b131253e8
- Cited by
- 50
- References
- 10
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 4 · 2016: 5 · 2015: 4 · 2014: 2 · 2013: 1
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial susceptibility, infective endocarditis, empirical antibiotic therapy, ceftriaxone, levofloxacin, clinical isolates
- MeSH terms
- Anti-Bacterial Agents, Ceftriaxone, Gram-Negative Bacteria, Microbial Sensitivity Tests, Ofloxacin, Levofloxacin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimicrobial Susceptibilities of Clinical Isolates of HACEK Organisms. https://app.cochat.ai/papers/10.1128/aac.00111-13
- The paper
- Coburn, B., Toye, B., Rawte, P., Jamieson, F. B., Farrell, D. J., & Patel, S. N. (2013). Antimicrobial Susceptibilities of Clinical Isolates of HACEK Organisms. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00111-13
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.